Rautou PE, Moucari R, Cazals-Hatem D. et al. - Levels and initial course of serum alanine aminotransférase can predict outcome of patients with Budd-Chiari syndrome. Clin Gastroenterol Hepatol, 2009, 7, 1230-1235.
Hadengue A, Poliquin M, Vilgrain V. et al. - The changing scene of hepatic venous thrombosis : recognition of asymptomatic cases. Gastroenterol, 1994, 106, 1042.
Rautou PE, Moucari R, Escolano S, et al. - Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol, 2009, 104, 1140-1146.
Moucari R, Rautou PE, Cazals-Hatem D, et al. - Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut, 2008, 57, 828-835.
Wang R, Meng Q, Qu L, et al. - Treatment of Budd- Chiari syndrome with inferior vena cava thrombosis. Exp Ther Med, 2013, 5, 1254-1258.
Wang L, Lu JP, Wang F, et al. - Diagnosis of Budd-Chiari syndrome: three-dimensional dynamic contrast enhanced magnetic resonance angiography. Abdom Imaging, 2011, 36, 399-406.
Wang ZG, Jones RS. - Budd-Chiari syndrome. Curr Probl Surg, 1996, 33, 83-211.
Rautou PE, Plessier A, Bernuau J, et al. - Pregnancy: a risk factor for Budd-Chiari syndrome? Gut, 2009, 58, 606-608.
Valla D, Casadevall N, Lacombe C, et al. - Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med, 1985, 103, 329-334.
Wang H, Sun G, Zhang P, et al. - JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients. J Gastroenterol Hepatol, 2014, 29, 208-214.
Mitchell MC, Boitnott JK, Kaufman S, et al. - Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore), 1982, 61, 199-218.
Sun YL, Fu Y, Zhou L, Ma X, et al. - Staged management of Budd-Chiari syndrome caused by co-obstruction of the inferior vena cava and main hepatic veins. Hepatobiliary Pancreat Dis Int, 2013, 12, 278-285.
Sun Y, Ma X, Feng L, et al. - Compensation by collateral circulation determines invasive therapeutic indications for patients with Budd-Chiari syndrome. Gut, 2012, 61, 1779-1780.
Darwish MS, Valla DC, de Groen PC, et al. - Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology, 2004, 39, 500-508.
Bansky G, Ernest C, Jenni R, et al. - Treatment of Budd-Chiari syndrome by dorsocranial liver resection and direct hepatoatrial anastomosis. J Hepatol, 1986, 2, 101-112.
Vogt PR, Andersson LC, Jenni R, et al. - Dorsocranial liver resection and direct hepatoatrial anastomosis for hepatic venous outflow obstruction: long-term outcome and functional results. Am J Gastroenterol, 1996, 91 (3), 539-544.
Murad D, Kamath PS. - Liver transplantation for Budd- Chiari syndrome: when is it really necessary? Liver Transpl, 2008, 14, 133-135.
